Btg Pactual Global Asset Management LTD Gilead Sciences, Inc. Call Options Transaction History

Btg Pactual Global Asset Management LTD

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $4.24 Million - $4.77 Million	-73,400 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $4.25 Million - $5.33 Million	73,400 New	73,400 $4.36 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $7.08 Million - $8.07 Million	-125,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $7.76 Million - $9.76 Million	125,000 New	125,000 $7.9 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Btg Pactual Global Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Btg Pactual Global Asset Management LTD with notifications on news.